| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 34 |
| 1 | SECUKINUMAB | 29 |
| 2 | ETANERCEPT | 19 |
| 3 | FOLIC ACID | 19 |
| 4 | INFLIXIMAB | 18 |
| 5 | ACETAMINOPHEN | 14 |
| 6 | OCRELIZUMAB | 12 |
| 7 | METHOTREXATE | 11 |
| 8 | METHOTREXATE SODIUM | 11 |
| 9 | PREDNISONE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFADROXIL | 5 | 0.0025 |
| 1 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 2 | NISOLDIPINE | 1 | 0.0008 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 5 | FLUOROMETHOLONE | 2 | 0.0006 |
| 6 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 7 | OMAVELOXOLONE | 1 | 0.0006 |
| 8 | ROPINIROLE HYDROCHLORIDE | 2 | 0.0005 |
| 9 | EFINACONAZOLE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Corticosteroid [EPC] | 23 |
| 3 | Vitamin C [EPC] | 22 |
| 4 | Vitamin B12 [EPC] | 20 |
| 5 | Vitamin D [EPC] | 19 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 17 |
| 7 | Benzodiazepine [EPC] | 16 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| 9 | Aminosalicylate [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 5 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 8 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 9 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |